09850222falseResearch and experimental development on biotechnology2022-11-012023-10-31http://www.companieshouse.gov.uk/2022-10-31http://www.companieshouse.gov.uk/pt:ShareCapital2022-10-31http://www.companieshouse.gov.uk/cd:Director12022-11-012023-10-31http://www.companieshouse.gov.uk/pt:ShareCapital2023-10-31http://www.companieshouse.gov.uk/cd:Director22022-11-012023-10-31http://www.companieshouse.gov.uk/cd:Director32022-11-012023-10-31http://www.companieshouse.gov.uk/pt:ToolsEquipment2022-10-31http://www.companieshouse.gov.uk/cd:Director42022-11-012023-10-31http://www.companieshouse.gov.uk/cd:OrdinaryShareClass12022-11-012023-10-31http://www.companieshouse.gov.uk/pt:ToolsEquipment2023-10-31http://www.companieshouse.gov.uk/cd:RegisteredOffice2022-11-012023-10-31http://www.companieshouse.gov.uk/cd:Director52022-11-012023-10-31http://www.companieshouse.gov.uk/cd:AuditExemptWithAccountantsReport2022-11-012023-10-31http://www.companieshouse.gov.uk/pt:CurrentFinancialInstruments2023-10-31http://www.companieshouse.gov.uk/pt:CurrentFinancialInstruments2022-10-31http://www.companieshouse.gov.uk/2022-11-012023-10-31http://www.companieshouse.gov.uk/2022-10-31http://www.companieshouse.gov.uk/cd:FRS1022022-11-012023-10-31http://www.companieshouse.gov.uk/2023-10-31http://www.companieshouse.gov.uk/cd:FullAccounts2022-11-012023-10-31http://www.companieshouse.gov.uk/cd:PrivateLimitedCompanyLtd2022-11-012023-10-31iso4217:GBPxbrli:sharesxbrli:pure
Registered number: 09850222

Telonostix Limited

ACCOUNTS
FOR THE YEAR ENDED 31/10/2023

Prepared By:
Staffer Mayled & Co Ltd
46-48 Station Road
Cardiff
CF14 5LU

Telonostix Limited

ACCOUNTS
FOR THE YEAR ENDED 31/10/2023
DIRECTORS
Duncan Martin Baird
Christopher Fegan
Christopher Pepper
Dr Joseph Thomas Birkett
Dr Rhodri Turner
REGISTERED OFFICE
30-36 Newport Road
Cardiff
CF24 0DE
COMPANY DETAILS
Private company limited by shares registered in EW - England and Wales, registered number 09850222
ACCOUNTANTS
Staffer Mayled & Co Ltd
46-48 Station Road
Cardiff
CF14 5LU

Telonostix Limited

ACCOUNTS
FOR THEYEARENDED31/10/2023
CONTENTS
Page
Directors' Report-
Accountants' Report-
Statement Of Comprehensive Income-
Balance Sheet3
Notes To The Accounts4
The following do not form part of the statutory financial statements:
Trading And Profit And Loss Account-
Profit And Loss Account Summaries-

Telonostix Limited

BALANCE SHEET AT 31/10/2023
20232022
Notes££
FIXED ASSETS
Tangible assets27751,035
CURRENT ASSETS
Stock3,5313,428
Debtors418,91533,750
Cash at bank and in hand58,44610,837
80,89248,015
CREDITORS: Amounts falling due within one year516,86119,349
NET CURRENT ASSETS64,03128,666
TOTAL ASSETS LESS CURRENT LIABILITIES64,80629,701
CREDITORS: Amounts falling due after more than one year671,46874,647
NET LIABILITIES(6,662)(44,946)
CAPITAL AND RESERVES
Called up share capital84040
Profit and loss account(6,702)(44,986)
SHAREHOLDERS' FUNDS(6,662)(44,946)
For the year ending 31/10/2023 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The directors have decided not to deliver to the registrar a copy of the company's profit and loss account.
Approved by the board on 26/07/2024 and signed on their behalf by
.............................
Duncan Martin Baird
Director

Telonostix Limited

NOTES TO THE ACCOUNTS
FOR THE YEAR ENDED 31/10/2023
1. ACCOUNTING POLICIES
1a. Basis Of Accounting
The accounts have been prepared under the historical cost convention.
The accounts have been prepared in accordance with FRS102 - The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006 .
1b. Going Concern
There was a net deficiency of assets of £82,604 at the balance sheet date, however the directors have confirmed continued support and consider the company retains sufficient working capital to continue trading for the foreseeable future
1c. Depreciation
Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives.
Equipmentreducing balance 25%
1d. Stocks
Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell (net realisable value). Costs, which comprise direct production costs, are based on the method most appropriate to the type of inventory class, but usually on a first-in-first-out basis. Overheads are charged to profit or loss as incurred. Net realisable value is based on the estimated selling price less any estimated completion or selling costs.
When stocks are sold, the carrying amount of those stocks is recognised as an expense in the period in which the related revenue is recognised. The amount of any write-down of stocks to net realisable value and all losses of stocks are recognised as an expense in the period in which the write-down or loss occurs. The amount of any reversal of any write-down of stocks is recognised as a reduction in the amount of stocks recognised as an expense in the period in which the reversal occurs.
1e. Pension Costs
The company operates a defined contribution pension scheme. The pension charge represents the amounts payable by the company to the fund in respect of the year.

Telonostix Limited

2. TANGIBLE FIXED ASSETS
EquipmentTotal
££
Cost
At 01/11/20222,9482,948
At 31/10/20232,9482,948
Depreciation
At 01/11/20221,9131,913
For the year260260
At 31/10/20232,1732,173
Net Book Amounts
At 31/10/2023775775
At 31/10/20221,0351,035
3. STOCK 20232022
££
Stock comprises:
Stock3,5313,428
3,5313,428
4. DEBTORS 20232022
££
Amounts falling due within one year
Trade debtors15,85533,480
Other debtors3,060270
18,91533,750
5. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
20232022
££
VAT5,2105,674
PAYE control56-
Directors current account-3,962
Bank Loan6,8026,802
Trade creditors3,1651,565
Deferred income1,6281,346
16,86119,349

Telonostix Limited

6. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
20232022
££
Loans >1yr71,46874,647
71,46874,647
In February 2018, the company took out a loan of £39,191. Simple interest of 8% on this amount applies annually, until the loan is repaid in full. Company has a right to repay the loan (inclusive of accrued interest) once they are ready. In May 2020, the company entered into a loan agreement of 72 payments of £566.82 plus interest of 2.5% p.a. above the base rate. No repayments are due for the first 12 months.
7. EMPLOYEES
20232022
No.No.
Average number of employees11
8. SHARE CAPITAL 20232022
££
Allotted, issued and fully paid:
40000 Class 1 shares of £.001 each4040
4040
9. CONTROLLING PARTY
The controlling party are the directors and shareholders of the company.
10. RELATED PARTY TRANSACTIONS